Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non-small-cell Lung Cancer.

Affiliation

Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address: [Email]

Abstract

Radiotherapy produces immune-promoting effects, which may be blunted by the delivery of corticosteroids (CS). We thus aimed to evaluate the impact of CS use on recurrence and survival outcomes of patients with early stage non-small-cell lung cancer treated with stereotactic ablative radiotherapy (SABR).

Keywords

Corticosteroid,Early stage lung cancer,Immunotherapy,SABR,SBRT,